MetaCap

Oculis Statistics

NASDAQ: OCSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.06-0.38 (-5.11%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Oculis by the numbers

Oculis has a market capitalization of $393.4 million based on 55.72M shares outstanding. With trailing EPS of $-1.69, Oculis is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.2% below its 50-day average and 59.3% below its 200-day average.

Average daily trading volume is 272.83K shares, or about $1.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

OCS valuation vs. peer median

OCS compared with the median of 8 peer companies
MetricOCSPeer medianDifference
Market cap$393.35M$403.05M-2%
Avg. volume272.83K1.44M-81%

Peer median across 8 companies: AVTX, IRD, PHAT, OVID, CRMD, PRTA, PBYI, ARVN.

Valuation

Price and trading

Previous close
7.44
Open
7.38
Day range
6.99 – 7.43
52-week range
6.78 – 34.48
52-week change
-63.34%
Beta
—
Volume
235.18K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
393.35M
Forward Pe
-3.92
Eps
-1.69
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
34.48
Week52 Low
6.78
Avg Volume
272.83K
Shares Outstanding
55.72M
Ma50
8.33
Ma200
17.35
Earnings Date
Nov 3, 2026
Pct From52w High
-79.52%
Pct From52w Low
4.13%

Related